0001104659-20-000872.txt : 20200103 0001104659-20-000872.hdr.sgml : 20200103 20200103161032 ACCESSION NUMBER: 0001104659-20-000872 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20200101 FILED AS OF DATE: 20200103 DATE AS OF CHANGE: 20200103 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Erlander Mark CENTRAL INDEX KEY: 0001651537 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-35558 FILM NUMBER: 20505379 MAIL ADDRESS: STREET 1: C/O TROVAGENE, INC. STREET 2: 11055 FLINTKOTE AVENUE, SUITE A CITY: SAN DIEGO STATE: CA ZIP: 92121 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Trovagene, Inc. CENTRAL INDEX KEY: 0001213037 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 272004382 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 11055 FLINTKOTE AVENUE CITY: SAN DIEGO STATE: CA ZIP: 92121 BUSINESS PHONE: 858-952-7570 MAIL ADDRESS: STREET 1: 11055 FLINTKOTE AVENUE CITY: SAN DIEGO STATE: CA ZIP: 92121 FORMER COMPANY: FORMER CONFORMED NAME: TrovaGene Inc. DATE OF NAME CHANGE: 20110830 FORMER COMPANY: FORMER CONFORMED NAME: XENOMICS INC DATE OF NAME CHANGE: 20040719 FORMER COMPANY: FORMER CONFORMED NAME: USED KAR PARTS INC DATE OF NAME CHANGE: 20030106 4 1 a4.xml 4 X0306 4 2020-01-01 0 0001213037 Trovagene, Inc. TROV 0001651537 Erlander Mark C/O TROVAGENE, INC. 11055 FLINTKOTE SAN DIEGO CA 92121 0 1 0 0 Chief Scientific Officer Common Stock 2020-01-01 4 M 0 1250 0 A 6783 D Common Stock 2020-01-03 4 F 0 552 0 D 6231 D Restricted Stock Units 2020-01-01 4 M 0 1250 0 D Common Stock 1250 521 D Represents the conversion upon vesting of restricted stock units into common stock (the "Converted Common Stock"). On July 24, 2018, the reporting person was granted 7,500 restricted stock units, 1,250 of which vested on January 1, 2020. Such restricted stock units were previously reported in Table II on a Form 4 filed with the Securities and Exchange Commission on July 26, 2018. The reporting person is reporting the withholding by Trovagene, Inc. of 552 shares of common stock to satisfy the reporting person's tax withholding obligations in connection with the delivery of the Converted Common Stock to the reporting person on January l, 2020. Each restricted stock unit is the economic equivalent of one share of Trovagene, Inc. common stock. On July 24, 2018, the reporting person was granted 7,500 restricted stock units, 1,250 of which vested on January 1, 2020. The common stock into which such vested restricted stock units converted on January 1, 2020 is reported in Table I on this Form 4. /s/ Mark Erlander 2020-01-03